Synthetic Methodology, SAR and Pharmacology of Commercialized Preparations Employing 1, 2, 4‐Triazole Analogues

Sucheta Singh,Meenakshi Kaira,Hrithik Dey,Kailash C. Pandey,Sumit Tahlan,Kuldeep Singh
DOI: https://doi.org/10.1002/slct.202404350
2024-11-27
ChemistrySelect
Abstract:This review explores the synthetic methodologies, structure‐activity relationships (SAR), and pharmacology of 1,2,4‐triazole derivatives. This review discusses various marketed formulations and clinical trial drugs to highlight their diverse biological activities and therapeutic applications. The emphasis is on their versatility in treating fungal infections, cancer, and central nervous system disorders, while showcasing emerging innovations and synthesis techniques for optimized drug design. The domain of medicinal chemistry has witnessed a notable surge of interest in triazoles owing to their unique structural characteristics and wide range of applications. The versatility of their synthesis methods has facilitated the creation of compound libraries with remarkable pharmacological activities, including antiviral, antiepileptic, anxiolytic, hypnotic/sedatives anticancer, antifungal, and antidepressant activities. Several techniques have been documented in the literature for generating 1,2,4‐triazole derivatives. The mechanisms governing the pharmacological effects of the formulations containing 1,2,4‐triazoles were elucidated and made clear. In addition to reviewing existing marketed formulations, this review explores emerging trends and innovations in this field. This review offers a comprehensive perspective on the importance of triazoles for influencing contemporary research, fostering innovation, and driving technological progress.
chemistry, multidisciplinary
What problem does this paper attempt to address?